论文部分内容阅读
目的:探讨应用硫酸镁治疗妊高症的临床疗效及安全性,总结其临床应用价值。方法:选取我院收治的60例妊高症患者作为研究对象,将其随机均分为观察组和对照组,对照组采用常规治疗,观察组给予静脉滴注联合肌注硫酸镁治疗,比较两组治疗后血压变化、临床症状的变化和治疗后并发症发生率,比较治疗有效率。结果:60例妊高症患者治疗后血压均明显下降,与对照组相比较,差异具有统计学意义(P<0.05)。观察组治疗后临床症状得到明显改善,治疗后仅有1例发生产后子痫并发症,经过治疗后痊愈,无其他严重的并发症发生,无新生儿死亡。结论:静脉滴注联合肌注硫酸镁治疗妊高症的临床疗效显著,不仅可以降低血压,而且可以减少妊高症引起的产后并发症的发生,可在临床上推广应用。
Objective: To investigate the clinical efficacy and safety of magnesium sulfate in the treatment of pregnancy-induced hypertension and to summarize its clinical value. Methods: 60 cases of pregnancy induced hypertension in our hospital were selected as the research object. They were randomly divided into observation group and control group. The control group was treated with conventional therapy. The observation group was given intravenous drip combined with intramuscular magnesium sulfate. After treatment, blood pressure changes, changes in clinical symptoms and incidence of postoperative complications, the treatment of more efficient. Results: The blood pressure of 60 patients with pregnancy induced hypertension were significantly decreased after treatment, compared with the control group, the difference was statistically significant (P <0.05). After treatment, the clinical symptoms of the observation group were significantly improved. Only 1 patient developed postpartum eclampsia after treatment. After treatment, it recovered and no other serious complications occurred. No neonatal death occurred. Conclusion: Intravenous infusion of intramuscular injection of magnesium sulfate in the treatment of pregnancy-induced hypertension is clinically significant, not only can lower blood pressure, but also reduce the incidence of postpartum complications caused by pregnancy-induced hypertension can be clinically promoted.